A Sequel to Sanger: amplicon sequencing that scales

Overview of attention for article published in BMC Genomics, March 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 88 X posts from 67 X users, with an upper bound of 169,603 followers.

A Sequel to Sanger: Amplicon Sequencing That Scales published as: https://t.co/GMmb47CaJM @BMC_series #biorxiv

A Sequel to Sanger: amplicon sequencing that scales. https://t.co/cIZ1zG2ksp

RT @alixcruse: EZ: Publication that shows validation that Sequel with CCS generates better quality and massively more throughput than Sange…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 84 additional X posts.